Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Roche Webinar

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. Aging Knowl. Environ., 24 July 2002
Vol. 2002, Issue 29, p. or8

OTHER RESOURCES

The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

John Hardy, and Dennis J. Selkoe

http://sageke.sciencemag.org/cgi/content/abstract/sageke;2002/29/or8

Abstract: Science 297, 353-356 (2002).

It has been more than 10 years since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid {beta}-peptide (A{beta}) in plaques in brain tissue. According to the amyloid hypothesis, accumulation of A{beta} in the brain is the primary influence driving AD pathogenesis. The rest of the disease process, including formation of neurofibrillary tangles containing tau protein, is proposed to result from an imbalance between A{beta} production and A{beta} clearance.

Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science of Aging Knowledge Environment. ISSN 1539-6150